Sign in Create account

Entero Healthcare Solutions Limited

Consumer Services · Retailing

NSE: ENTERO BSE: 544122
₹1708.90
▼ -56.00 (-3.17%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
50/100
Moderate
Valuation
45/100
Fairly Valued
Momentum
50/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹7,438 Cr
PE (TTM)
318.8
Industry median 38.7 (39 companies)
Price to Book
4.2
PEG (TTM)
0.9
Institutions holding %
19.85%
FII + DII, latest filed period
Piotroski Score
2
Relative return vs Nifty50, qtr %
52.3
Relative return vs Sector, qtr %
56.8
Free Cash Flow
₹29 Cr
as of March 31, 2026
Industry median ₹1 Cr (69 companies)
EPS Growth (YoY)
-50.63%
as of June 30, 2026
Industry median 7.14% (47 companies)
Net Profit Growth (TTM)
-68.64%
as of June 30, 2026
Industry median 19.53% (42 companies)
Operating Revenue Growth (TTM)
-3.69%
as of June 30, 2026
Industry median 10.76% (43 companies)
Profit Growth (YoY)
-50.31%
as of June 30, 2026
Industry median 8.70% (47 companies)
Revenue Growth (YoY)
4.93%
as of June 30, 2026
Industry median 13.18% (45 companies)
Current Ratio
1.58
as of March 31, 2026
Industry median 2.01 (67 companies)
Debt to Equity
0.32
as of March 31, 2026
Industry median 0.04 (54 companies)
Interest Coverage
3.63
as of June 30, 2026
Industry median 5.12 (51 companies)
Net Margin
4.15%
as of June 30, 2026
Industry median 6.65% (48 companies)
Operating Margin (EBIT)
12.43%
as of June 30, 2026
Industry median 8.41% (50 companies)
Operating Margin (TTM)
10.05%
as of June 30, 2026
Industry median 7.79% (51 companies)
Return on Assets
4.05%
as of March 31, 2026
Industry median 4.36% (49 companies)
Return on Capital Employed
11.61%
as of March 31, 2026
Industry median 11.79% (48 companies)
Return on Equity
8.32%
as of March 31, 2026
Industry median 9.52% (48 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 2)
  • Yes Debt to equity is below 0.5 (0.32)
  • No Return on equity is 15% or more (8.3%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.2%
Low 1701.0000 · High 1775.3000
1W return
-7.3%
Low 1701.0000 · High 1875.0000
1M return
-5.6%
Low 1610.8000 · High 1920.0000
52W return
55.8%
Low 944.0000 · High 1920.0000
Lifetime High ₹1898.4000 (Sept. 7, 2026)
Lifetime Low ₹949.2000 (Dec. 29, 2025)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
1766.7
10D
1779.8
20D
1756.1
50D
1610.1
100D
1454.9
200D
1250.6

Delivery and volume

Day avg. delivery
61.2%
Week avg. delivery
59.1%
Month avg. delivery
55.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1728.40
Pivot
First resistance1755.80
Second resistance1802.70
Third resistance1830.10
First support1681.50
Second support1654.10
Third support1607.20
Day RSI48.6
Day MFI29.8
Day MACD51.48
Day MACD signal75.73

Beta

1M0.10
3M0.29
1Y0.26
3Y0.41

Price change analysis

↓ -5.6%
Over 1 Month
LowHigh
1610.801920.00
↑ 43.7%
Over 3 Months
LowHigh
1164.701920.00
↑ 37.1%
Over 6 Months
LowHigh
1082.001920.00
↑ 55.8%
Over 1 Year
LowHigh
944.001920.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 318.8 (own history: 67.8–948.1)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹83 Cr
Net profit (June 30, 2026)
₹3 Cr
Basic EPS (June 30, 2026)
₹0.7900

Ranks #20 of 52 in Retailing by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter52.40%
  • Mutual funds8.97%
  • FII/FPI4.37%
  • Other DII6.51%
  • Public27.75%

Largest holders

NameCategoryShares %Shares
Orbimed Asia III Mauritius LimitedPromoter38.0000%16538929
SURBHI SINGH(PRASID UNO FAMILY TRUST)Public10.4500%4550320
Prabhat AgrawalPromoter9.2600%4028395
Prem SethiPromoter5.1500%2239842
Invesco India Aggressive Hybrid FundPublic4.3100%1874455

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 52.42% to 52.40% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 4.03% to 4.37% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 9.52% to 8.97% in Jun 2026 qtr

7 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 3 insider trades, 17 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
31 Aug 2024 Jayant Prakash Key managerial personnel Sell 0 ₹0
22 Aug 2024 Jayant Prakash Key managerial personnel Sell 0 ₹0
21 Aug 2024 Abhitesh Kumar Other Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 41 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
18 Sep 2026 PRASID UNOFAMILY TRUST Block Sell 168,180 1695.0000 NSE
18 Sep 2026 PRASID UNO FAMILY TRUST Block Sell 1,221,820 1695.0000 NSE
18 Sep 2026 HDFC MUTUAL FUND Block Buy 1,390,000 1695.0000 NSE
18 Sep 2026 PRASID UNO FAMILY TRUST Bulk Sell 1,221,820 1695.0000 NSE
18 Sep 2026 HDFC MUTUAL FUND Bulk Buy 1,390,000 1695.0000 NSE
18 Sep 2026 PRASID UNOFAMILY TRUST Block Sell 168,180 1695.0000 NSE
18 Sep 2026 PRASID UNO FAMILY TRUST Block Sell 1,221,820 1695.0000 NSE
18 Sep 2026 HDFC MUTUAL FUND Block Buy 1,390,000 1695.0000 NSE
18 Sep 2026 PRASID UNO FAMILY TRUST Bulk Sell 1,221,820 1695.0000 NSE
18 Sep 2026 HDFC MUTUAL FUND Bulk Buy 1,390,000 1695.0000 NSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
7 Aug 2026 Financial Results/Other business matters Yes
25 May 2026 Financial Results/Other business matters Yes
12 Feb 2026 Financial Results Yes
12 Nov 2025 Financial Results Yes
8 Aug 2025 Financial Results Yes

Corporate Announcements

All 265 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
23 Sep 2026 Trading Window Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
22 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
12 Sep 2026 Company Update Entero Healthcare Solutions Ltd - 544122 - Entero Healthcare Solutions Limited Has Informed The Exchange About General Updates
12 Sep 2026 General Updates Entero Healthcare Solutions Limited has informed the Exchange about General Updates
24 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
24 Aug 2026 Change in Management Completion of tenure of Mr. Rajesh Shashikant Dalal
19 Aug 2026 Shareholders meeting Entero Healthcare Solutions Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 19, 2026. Further, the company has submitted the Exchange a copy of Scrutinizers report along with voting results.
17 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Entero Healthcare Solutions Limited has informed the Exchange about Transcript
10 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording on Unaudited Financial Results of the Company for the quarter ended June 30, 2026
8 Aug 2026 Copy of Newspaper Publication Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication for Unaudited Financial Results for the quarter ended June 30, 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.58)

Weaknesses

  • Low Return on Equity (8.3%)
  • Thin net profit margin (4.2%)
  • Declining profit YoY (-50.3%)

Opportunities

  • PEG below 1 (0.93) -- earnings growth outpacing its own valuation

Threats

  • PE above 35 (318.8) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Entero Healthcare Solutions Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.